TFF Pharmaceuticals Income Statement

Financials in millions EUR. Fiscal year is May - April.

Millions EUR. Fiscal year is May - Apr.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Revenue	425.43	486.55	439.79	302.62	260.88
Revenue Growth (YoY)	-12.56%	10.63%	45.33%	16.00%	-6.72%
Cost of Revenue	240.34	279.86	261.85	186.67	155.5
Gross Profit	185.09	206.7	177.94	115.94	105.38
Selling, General & Admin	102.95	97.28	82.68	64.04	55.84
Other Operating Expenses	2.99	2.17	2.2	1.28	0.48
Operating Expenses	124.61	114.93	98.81	77.6	68.55
Operating Income	60.49	91.76	79.13	38.34	36.83
Interest Expense	-16.09	-12.91	-4.2	-0.95	-1.2
Interest & Investment Income	3.88	3.06	0.58	0.24	0.28
Earnings From Equity Investments	0.54	1.23	1.4	0.4	0.52
Currency Exchange Gain (Loss)	-3.87	3.78	-4.5	12.97	-9.35
Other Non Operating Income (Expenses)	0.01	0	0	-	-
EBT Excluding Unusual Items	44.95	86.93	72.41	51.01	27.08
Other Unusual Items	-1.03	-0.16	-0.04	-0.23	0.61
Pretax Income	43.92	86.77	72.37	50.78	27.69
Income Tax Expense	12.11	28.36	18.03	14.19	7.18
Earnings From Continuing Operations	31.81	58.41	54.33	36.59	20.5
Minority Interest in Earnings	-1.11	-1.96	-1.51	-0.73	-0.46
Net Income	30.71	56.45	52.82	35.86	20.04
Net Income to Common	30.71	56.45	52.82	35.86	20.04
Net Income Growth	-45.60%	6.87%	47.30%	78.93%	-24.76%
Shares Outstanding (Basic)	22	22	22	22	22
Shares Outstanding (Diluted)	22	22	22	22	22
Shares Change (YoY)	-0.03%	-0.00%	0.01%	-0.01%	0.03%
EPS (Basic)	1.42	2.60	2.44	1.65	0.92
EPS (Diluted)	1.42	2.60	2.44	1.65	0.92
EPS Growth	-45.50%	6.69%	47.69%	79.35%	-25.14%
Free Cash Flow	-17.53	-55.72	-29.16	17.98	40.4
Free Cash Flow Per Share	-0.81	-2.57	-1.34	0.83	1.86
Dividend Per Share	0.500	0.600	0.400	0.400	0.350
Dividend Growth	-16.67%	50.00%	-	14.29%	-
Gross Margin	43.51%	42.48%	40.46%	38.31%	40.39%
Operating Margin	14.22%	18.86%	17.99%	12.67%	14.12%
Profit Margin	7.22%	11.60%	12.01%	11.85%	7.68%
Free Cash Flow Margin	-4.12%	-11.45%	-6.63%	5.94%	15.49%
EBITDA	79.23	107.24	93.05	50.63	49.05
EBITDA Margin	18.62%	22.04%	21.16%	16.73%	18.80%
D&A For EBITDA	18.75	15.48	13.93	12.29	12.23
EBIT	60.49	91.76	79.13	38.34	36.83
EBIT Margin	14.22%	18.86%	17.99%	12.67%	14.12%
Effective Tax Rate	27.57%	32.68%	24.92%	27.95%	25.95%
Revenue as Reported	425.4	491.26	443.77	305.48	259.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q